Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues

American Journal of Pathology

Volumn 150, Issue 4, 1997, Pages 1275-1284

  Wahl, Sharon M ^a   Worley, Paula ^a   Jin, Wenwen ^a   McNeely, Tessie B ^a   Eisenberg, Steve ^b   Fasching, Claudia ^c   Orenstein, Jan M ^d   Janoff, Edward N ^c  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b AMGEN INC   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; SALIVARY GLAND; VIRUS INHIBITION; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIVIRAL AGENTS; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; KINETICS; MOUTH MUCOSA; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; SALIVA; SALIVARY GLANDS; SALIVARY PROTEINS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SERINE PROTEINASE INHIBITORS;

EID: 0030902079     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Levy JA: HIV and the Pathogenesis of AIDS. Washington, DC, ASM Press, 1994
2. Hussain LA, Lehner T: Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary, and rectal epithelia. Immunology 1995, 85:475-484
3. Wahl SM, McNeely TB, Shugars D, Worley P, Tucker C, Orenstein JM, Janoff EN: Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-1. Oral Dis 1997 (in press)
4. Yeh CH, Fox PC, Goto Y, Austin HA, Brahim JS, Fox CH: Human immunodeficiency virus (HIV) and HIV infected cells in saliva and salivary glands of a patient with systemic lupus erythematosus, J Rheumatol 1992, 19:1810-1812
5. Labouyrie E, Merlio JP, Beylot-Barry M, Delord B, Vergier B, Brossard G, Lacoste D, Beylot J, Leng B, Fleury H: Human immunodeficiency virus type 1 replication within cystic lymphoepithelial lesions of the salivary gland, Am J Clin Pathol 1993, 100:41-46
6. Tunkel DE, Loury MC, Fox CH, Goins MA, Johns ME: Bilateral parotid enlargement in HIV-seropositive patients. Laryngoscope 1989, 99:590-595
7. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM: Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-HIV-1 activity In vitro. J Clin Invest 1995, 96:456-464
8. Thompson RC, Ohlsson K: Isolation, properties, and complete amino acid sequences of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 1986, 83:6692-6696
9. Stetler G, Brewer MT, Thompson RC: Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases, Nucleic Acids Res 1986, 14: 7883-7876
10. Grutter MG, Fendrich G, Huber R, Bode W: The 2.5 Å x-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine α-chymotrypsin, EMBO J 1988, 7:345-351
11. Eisenberg SP, Hale KK, Heimdal P, Thompson RC: Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J Biol Chem 1990, 265: 976-7981
12. Ying QL, Kemme M, Simon SR: Functions of the N-terminal domain of secretory leukoprotease inhibitor. Biochemistry 1994, 33:5445-5450
13. Fritz H: Human mucus proteinase inhibitor (human MPI): human seminal inhibitor I (HUSH-I), antileuco-protease (ALP): secretory leukocyte protease inhibitor (SLPI). Biol Chem 1988, 369:79-82
14. Abe T, Kobayashi N, Yoshimura K, Trapnell BC, Kim H, Hubbard RC, Brewer MT, Thompson RC, Crystal RG: Expression of the secretory leukoprotease inhibitor gene in epithelial cells. J Clin Invest 1991, 87:2207-2215
15. Ohlsson M, Fryksmark U, Polling A, Tegner H, Ohlsson K: Localization of antileukoprotease in the parotid and the submandibular salivary glands. Acta Otolaryngol 1984, 98:147-151
16. Stromatt SC: Secretory leukocyte protease inhibitor in cystic fibrosis. Proteases, Protease Inhibitors and Protease-Derived Peptides. Basel, Birkhäuser Verlag, 1993, pp 103-110
17. McNeely TB, Shugars DC, Rosendahl M, Tucker C, Eisenberg SP, Wahl SM: Inhibition of HIV-1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood 1997 (in press)
18. Wagner RP, Tian H, McPherson MJ, Latham PS, Orenstein JM: AIDS-associated infections in salivary glands: autopsy survey of 60 cases. Clin Infect Dis 1996, 22: 369-371
19. Czerkinsky C, Svennerholm AM, Quiding M, Jonsson R, Holmgren: Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans, Infect Immun 1991, 59:996-1001
20. Fox CH, Koenig S, Fauci AS: In situ hybridization for molecular diagnosis. Protocols for in situ Hybridization, Rockville, MD, Lofstrand Laboratories, 1989
21. Wahl SM, Allen JB, McCartney-Francis N, Morganti-Kossman MC, Kossman T, Ellingson L, Mergenhagen SE, Orenstein JM: Transforming growth factor-β: a potential macrophage and astrocyte-derived mediator of CMS dysfunction in AIDS. J Exp Med 1991, 173:891-899
22. Shirasuna K, Sato M, Miyazaki T: A neoplastic epithelial duct cell line established from an irradiated human salivary gland. Cancer 1981, 48:745-752
23. Wahl LM, Katona IM, Wilder RL, Winter CC, Haraoui B, Sher I, Wahl SM: Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation. I. Characterization of B lymphocyte, T lymphocyte and monocyte-enriched fractions by flow cytometric analysis. Cell Immunol 1984, 85:373-383
24. Allen JB, McCartney-Francis N, Smith PD, Simon G, Gartner S, Wahl LM, Popovic M, Wahl SM: Expression of interleukin 2 receptors by monocytes from patients with acquired immunodeficiency syndrome and induction of monocyte interleukin 2 receptors by human immunodeficiency virus in vitro. J Clin Invest 1990, 85; 192-199
25. Finberg RW, Wahl SM, Allen JB, Soman G, Strom TB, Murphy JR, Nichols JC: Selective elimination of HIV-1 infected cells with an interleukin-2 receptor-specific cytotoxin. Science 1991, 252:1703-1705
26. Szebeni J, Wahl SM, Popovic M, Wahl LM, Gartner S, Fine RL, Skaleric U, Weinstein JN: Dipyridamole potentiates the inhibition by 3′ azido-3′-deoxythymidine and other dideoxynucleosides of human immunodeficiency virus replication in monocyte/macrophages. Proc Natl Acad Sci USA 1989, 86:3842-3846
27. Wahl SM, Allen JB, Gartner S, Orenstein JM, Popovic M, Chenoweth DE, Arthur LO, Farrar WL, Wahl LM: HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes, J Immunol 1989, 142:3555-3559
28. Schiodt M: HIV-associated salivary gland disease: a review, Oral Surg 1992, 73:164-167
29. Opstad NL, Daley CL, Thurn JR, Rubins JB, Merrifield C, Hopewell PC, Janoff EN: Impact of Streptococcus pneumoniae bacteremia and human immunodeficiency virus type 1 on oral mucosal immunity, J Infect Dis 1995, 172:566-570
30. Fox PC, Wolff A, Yeh C-K, Atkinson JC, Baum BJ: Saliva inhibits HIV-1 infectivity. J Am Dent Assoc 1988, 116: 635-637
31. Bergey EJ, Cho MI, Blumberg BM, Hammarskjold ML, Rekosh D, Epstein LG, Levie MJ: Interaction of HIV-1 and human salivary mucins. J Acquired Immune Deficiency 1994, 7:995-1002
32. Greenspan JS, Greenspan D: Oral lesions associated with HIV infection. AIDS and Other Manifestations of HIV Infection, ed 2. Edited by G Wormer. New York, Raven Press, 1992, pp 489-498
33. Kramps JA, Franken C, Meyer CJL, Dijkman JH: Localization of a low molecular weight protease inhibitor in serous secretory cells of the respiratory tract. Histochem Cytochem 1981, 29:712
34. Malamud D, Freidman HM: HIV in the oral cavity: virus, viral inhibitory activity, and antiviral antibodies: a review, Crit Rev Oral Biol Med 1993, 4:461-466
35. Fultz P: Components of saliva inactivate human immunodeficiency virus. Lancet 1986, ii:1215
36. Groopman JE, Salahuddin SZ, Sarngadharan MG, Markham PD, Gonda M, Sliski A, Gallo RC: HTLV III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS, Science 1984, 226: 447-449
37. Yeung SC, Kazazi F, Randle CG, Howard RC, Rizvi N, Downie JC, Donovan BJ, Cooper DA, Sekine H, Dwyer DE: Patients infected with human immunodeficiency virus type I have low levels of virus in saliva even in the presence of periodontal disease. J Infect Dis 1993, 167:803-809
38. Barr CE, Miller LK, Lopez MR, Croxson TS, Schwartz SA, Denman H, Jandorek R: Recovery of infectious HIV-1 from whole saliva. J Am Dent Assoc 1992, 123: 36-48
39. Moore BE, Flaitz CM, Coppenhaver DH, Nichols M, Kalmaz GD, Bessman JD, Cloyd MW, Lynch DP, Prabhakar BS, Baron S: HIV recovery from saliva before and after dental treatment: inhibitors may have critical role in viral inactivation, J Am Dent Assoc 1993, 124:67-74
40. Goto Y, Yeh C-K, Notkins AL, Prabhakar BS: Detection of proviral sequences in saliva of patients infected with human immunodeficiency virus type I. AIDS Res Hu- man Retrovir 1991, 7:343-347
41. Ho DD, Byington RE, Schooley RT, Flynn T, Rota TR, Hirsch MS: Infrequency of isolation of HTLV-III virus from saliva in AIDS. N Engl J Med 1985, 313:1606
42. Baba TW, Trichel AM, An L, Liska V, Martin LN, Murphey-Corb M, Ruprecht RM: Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science 1996, 272:1486-1489
43. Lifson AR: HIV seroconversion in two homosexual men after receptive oral intercourse with ejaculation: implications for counseling concerning safe sexual practices. Am J Public Health 1990, 80:1509-1511
44. Schiott CR, Loe H: The origin of and variation in number of leukocytes in the human saliva. J Periodont Res 1970, 5:6-41
45. Franken C, Meijer CJLM, Dijkman JH: Tissue distribution of antileukoprotease and lysozyme in humans. J Histochem Cytochem 1989, 37:493-498
46. Fryksmark U, Prellner T, Tegner H, Ohlsson K: Studies on the role of antileukoprotease in respiratory tract disease. Eur J Respir Dis 1984, 65:201-209